Introduction: Health economics education (HEe) and pharmacoeconomics education (PEe) in the Middle East and North Africa area is growing, particularly in pharmacy education. Little is known about the awareness, knowledge, and attitudes of health professions students toward health economics (HE) and pharmacoeconomics (PE) and the extent of education they receive before joining the workforce.
Methods: A self-completed validated questionnaire was distributed to students from medical, dental, pharmacy, and nursing schools in Jordan. The questionnaire assessed awareness, knowledge, and attitudes about HE and PE terminologies, applications, and need for training. Chi-square and Kruskal-Wallis H tests were used to outline the differences between students' responses.
Results: A total of 2648 questionnaires were analysed, representing 586 medical, 414 dental, 1080 pharmacy, and 568 nursing students. Approximately 65% of respondents reported they had heard of HE or PE. Supportive views about the necessity for economic education in healthcare professions curricula were reported. Nursing students most often expressed desire to undertake training before graduation while dental students showed the least interest.
Conclusions: Students across health professions groups acquire various extents of HEe and PEe before graduation. Pharmacy schools demonstrated leading interest and progress in providing PEe in Jordan, and medical schools appeared to follow. Both dental and nursing schools were lagging. Regional support from the International Society for Pharmacoeconomics and Outcomes Research Arabic Network, accreditation, and regulatory requirements are leading social and contextual contributors to PEe in Jordan.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.cptl.2020.04.027 | DOI Listing |
Alzheimers Dement
December 2024
Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan.
In Japan, the regulatory authority approved the drug in September 2023, and on December 20, it became available for prescription country-wide under the health insurance system. However, there are strict patient, physician, and facility requirements for the prescription of Lecanemab, and various problems are anticipated in its future implementation and widespread use in society. Lecanemab is the first anti-Aβ antibody in Japan, and even dementia specialists do not have sufficient knowledge and experience in its introduction, evaluation of efficacy, and evaluation and handling of side effects.
View Article and Find Full Text PDFUp to date, there are no precise reports of the prevalence of dementia with Lewy bodies (DLB) in Latin America. This can be explained by the lack of research studies and general little awareness about the disease. Notably, collaborative clinical studies are lacking, and DLB patients remain underrepresented despite their significant morbidity.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
Universidade Federal de São Paulo (UNIFESP), São Paulo, São Paulo/SP, Brazil.
Background: Dementia awareness and education are currently limited among healthcare workers and the general public, contributing towards the generation and propagation of stigma and discrimination against people with dementia worldwide. It is crucial to promote evidence-based anti-stigma interventions with a focus on stigma reduction.
Method: This is a randomized and controlled feasibility trial of a group intervention aimed at improving knowledge and reducing stigma related to dementia among Community Health Workers (CHWs) (Trial Registration: RBR-10xp637m).
Alzheimers Dement
December 2024
Alzheimer's Association, Columbus, OH, USA.
Background: Older Black Americans are twice as likely to have Alzheimer's Disease or another dementia, and 65% of Black Americans say that they know somebody with Alzheimer's or dementia. More locally, according to Ohio county level estimates, 11.3% of Ohioans aged 65 are currently living with Alzheimer's Disease.
View Article and Find Full Text PDFAlzheimers Dement
December 2024
NIA-Layton Aging & Alzheimer's Disease Research Center, Portland, OR, USA.
Background: Current research around caregiving for person's with dementia (PWD) has historically emphasized caregiver burden. This leaves a gap of knowledge around other contributors to caregiving's long-term effects, including grief. The current analysis explores the relationship between caregiver grief and quality-of-life.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!